---
title: "LPCH TPN Reference (Neonates/Infants)"
source: "Lucile Packard Children's Hospital (LPCH) - TPN Reference Chart"
scope: "Neonatal (NICU, ICN, SEQN, NN, WBN) and Pediatric (CVICU, PICU, Acute Care Units)"
transcribed: "2026-02-06"
---

# LPCH TPN REFERENCE (Neonates/Infants)

## Overview

This reference covers TPN parameters for:
- **Neonatal Units**: NICU, ICN, SEQN, NN, WBN
- **Pediatric Units**: CVICU, PICU, Acute Care Units

---

## Parameters Table

### Osmolarity

| Setting | Value |
|---------|-------|
| **Initial Dose** | — |
| **Dose Advance** | N/A |
| **Goal** | 950 mOsm/L peripheral; 2300 mOsm/L central |
| **Max Dose in Protocol (Neonatal)** | — |
| **Overridable by Pharmacist?** | No |
| **Absolute Max (NOT overridable) (Neonatal)** | 950 mOsm/L peripheral; 2300 mOsm/L central |
| **Max Dose in Protocol (Pediatric)** | 950 mOsm/L peripheral |
| **Overridable by Pharmacist? (Pediatric)** | — |
| **Absolute Max (NOT overridable) (Pediatric)** | 950 mOsm/L peripheral; NONE - central |
| **Notes** | Institution and unit specific |

---

### Trophamine (Amino Acids)

| Setting | Value |
|---------|-------|
| **Initial Dose** | 3-3.5 g/kg/d or as volume allows |
| **Dose Advance** | Max to goal |
| **Goal** | 3.5 g/kg/d (term); 4 g/kg/d (preterm) |
| **Max Dose in Protocol (Neonatal)** | 4 g/kg |
| **Overridable by Pharmacist?** | — |
| **Absolute Max (NOT overridable) (Neonatal)** | 3.1% peripheral; 4% central |
| **Max Dose in Protocol (Pediatric)** | 4 g/kg |
| **Absolute Max (NOT overridable) (Pediatric)** | 3.1% peripheral; 4% central |
| **Notes** | *CVICU: protein usually max for patients with fluid restriction and severe malnutrition (attempt to maximize to goal once TPN volume liberalized). *NICU: Advance daily unless renal disease or severe azotemia exists (BUN >50-60) |

---

### Dextrose

| Setting | Value |
|---------|-------|
| **Initial Dose** | <1.5 kg: GIR 4-6; ≥1.5 kg: KGIR 6-8 |
| **Dose Advance** | GIR 1-2 (up to 3 may be ok) |
| **Goal** | GIR 10-14 (max usually up to 18) |
| **Max Dose in Protocol (Neonatal)** | 12.5% peripheral; 30% central |
| **Overridable by Pharmacist?** | No |
| **Absolute Max (NOT overridable) (Neonatal)** | 12.5% peripheral; 30% central |
| **Max Dose in Protocol (Pediatric)** | 12.5% peripheral; 30% central |
| **Overridable by Pharmacist? (Pediatric)** | No |
| **Absolute Max (NOT overridable) (Pediatric)** | 12.5% peripheral; 30% central |
| **Notes** | *CVICU: Higher GIR may be recommended if severely malnourished. GIR (mg/kg/min) = % Dextrose × rate of infusion (mL/hr) ÷ 10 ÷ Weight (kg) × 6 ÷ 11 |

---

### Intralipid

| Setting | Value |
|---------|-------|
| **Initial Dose** | 0.5-1 g/kg/day |
| **Dose Advance** | 0.5-1 g/kg/day |
| **Goal** | 3 g/kg/day |
| **Max Dose in Protocol (Neonatal)** | 3 g/kg (max 99 g) |
| **Overridable by Pharmacist?** | Yes |
| **Absolute Max (NOT overridable) (Neonatal)** | None |
| **Max Dose in Protocol (Pediatric)** | 3 g/kg (max 99 g) |
| **Overridable by Pharmacist? (Pediatric)** | Yes |
| **Absolute Max (NOT overridable) (Pediatric)** | None |
| **Notes** | *NICU: consider reducing dose if TG >250 (non-NICU consider holding/reducing dose if TG >400). *Minimum intralipid to prevent EFAD: 0.5-1.5 g/kg/day |

---

### Omegaven

| Setting | Value |
|---------|-------|
| **Initial Dose** | 0.5-1 g/kg/day |
| **Dose Advance** | 0.5-1 g/kg/day |
| **Goal** | 1.5 g/kg/day |
| **Max Dose in Protocol (Neonatal)** | 1.5 g/kg (max 155 g) |
| **Overridable by Pharmacist?** | Yes |
| **Absolute Max (NOT overridable) (Neonatal)** | None |
| **Max Dose in Protocol (Pediatric)** | 1.5 g/kg (max 55 g) |
| **Overridable by Pharmacist? (Pediatric)** | Yes |
| **Absolute Max (NOT overridable) (Pediatric)** | None |
| **Notes** | *Minimum SMOFlipid to prevent EFAD: 1.5-2.5 g/kg/day. *Lipids should not >60% total daily calories (except ketogenic diet). *CVICU: May need to hold lipids if severe fluid restriction. *Usually hold lipids if on dexlipidine or propofol. *SMOF restricted on formulary if no drug shortage; Omegaven restricted on formulary |

---

### SMOFlipid

| Setting | Value |
|---------|-------|
| **Initial Dose** | 0.5-1 g/kg/day |
| **Dose Advance** | 0.5-1 g/kg/day |
| **Goal** | 3 g/kg/day |
| **Max Dose in Protocol (Neonatal)** | 3 g/kg (max 99 g) |
| **Overridable by Pharmacist?** | Yes |
| **Absolute Max (NOT overridable) (Neonatal)** | None |
| **Max Dose in Protocol (Pediatric)** | 3 g/kg (max 99 g) |
| **Overridable by Pharmacist? (Pediatric)** | Yes |
| **Absolute Max (NOT overridable) (Pediatric)** | None |
| **Notes** | (See Omegaven notes above for shared lipid guidance) |

---

### Zinc

| Setting | Value |
|---------|-------|
| **Initial Dose** | <3kg: 400 mcg/kg/d; 3-10 kg: 250 mcg/kg/d |
| **Dose Advance** | Per lab |
| **Goal** | Per lab |
| **Max Dose in Protocol (Neonatal)** | 400 mcg/kg/d <3 kg; 250 mcg/kg/d 3-20 kg |
| **Overridable by Pharmacist?** | Yes |
| **Absolute Max (NOT overridable) (Neonatal)** | None |
| **Max Dose in Protocol (Pediatric)** | 400 mcg/kg/d <3 kg; 100 mcg/kg/d 10-40 kg; 5 mg/d >40 kg |
| **Overridable by Pharmacist? (Pediatric)** | Yes |
| **Absolute Max (NOT overridable) (Pediatric)** | None |
| **Notes** | *Highly bound to albumin. *Helps with wound healing |

---

### Pediatric MVI

| Setting | Value |
|---------|-------|
| **Initial Dose** | 2 mL/kg/day (max 5 mL) |
| **Dose Advance** | — |
| **Goal** | — |
| **Max Dose in Protocol (Neonatal)** | 2 mL/kg up to 2.5 kg; 3 mL < 11 y/o |
| **Overridable by Pharmacist?** | Yes |
| **Absolute Max (NOT overridable) (Neonatal)** | None |
| **Max Dose in Protocol (Pediatric)** | 2 mL/kg up to 2.5 kg; 3 mL < 11 y/o |
| **Overridable by Pharmacist? (Pediatric)** | Yes |
| **Absolute Max (NOT overridable) (Pediatric)** | None |
| **Notes** | During shortage, protocol for patients with PMA >44 wks: MVI Monday-Wednesday, thiamine 10 mg Thursday |

---

### Sodium

| Setting | Value |
|---------|-------|
| **Initial Dose** | 0-1 mEq/kg/day |
| **Dose Advance** | Per lab |
| **Goal** | 3-6 mEq/kg/day or per lab |
| **Max Dose in Protocol (Neonatal)** | 9.9 mEq/kg |
| **Overridable by Pharmacist?** | Yes |
| **Absolute Max (NOT overridable) (Neonatal)** | 300 mEq/L |
| **Max Dose in Protocol (Pediatric)** | 9 mEq/kg |
| **Overridable by Pharmacist? (Pediatric)** | Yes |
| **Absolute Max (NOT overridable) (Pediatric)** | 300 mEq/L |
| **Notes** | *Usually minimized on 1st day of life (but enough to provide some phos and acetate if needed). *Diuretics associated with hyponatremia (NICU maintain serum Na >130). *Neurosurgery may need higher Na. *Review final concentration (NS 154 mEq/L; 1/2NS 77 mEq/L) |

---

### Potassium

| Setting | Value |
|---------|-------|
| **Initial Dose** | 0-2 mEq/kg/day or per lab (neonates usually no K on 1st day of life) |
| **Dose Advance** | Titrate based on needs, repletions, labs |
| **Goal** | 2-6 mEq/L |
| **Max Dose in Protocol (Neonatal)** | 9 mEq/kg |
| **Overridable by Pharmacist?** | Yes |
| **Absolute Max (NOT overridable) (Neonatal)** | 40 mEq/L peripheral; 120 mEq/L central |
| **Max Dose in Protocol (Pediatric)** | 9 mEq/kg |
| **Overridable by Pharmacist? (Pediatric)** | Yes |
| **Absolute Max (NOT overridable) (Pediatric)** | 40 mEq/L peripheral; 120 mEq/L central |
| **Notes** | *Renally cleared electrolyte. *Cardiac patients will have K goal levels. *Dose adjustment impacted by repletion doses, diuretic changes, and organ function, enteral repletions, drug-related hypo/hyperkalemia. *Max infusion rate: 0.5 mEq/kg/hr |

---

### Calcium

| Setting | Value |
|---------|-------|
| **Initial Dose** | 400-500 mg/kg/d central (100-200 mg/kg/day peripheral) |
| **Dose Advance** | Increase by max allowed up to goal |
| **Goal** | <1.5 kg: 350-500 mg/kg/day; Term infants (up to 1 year): 300 mg/kg/day |
| **Max Dose in Protocol (Neonatal)** | 850 mg/kg (NICU usually prefers max 200 mg/kg for peripheral TPN) |
| **Overridable by Pharmacist?** | Yes |
| **Absolute Max (NOT overridable) (Neonatal)** | 3 g/L peripheral; 8 g/L central |
| **Max Dose in Protocol (Pediatric)** | 600 mg/kg |
| **Overridable by Pharmacist? (Pediatric)** | Yes |
| **Absolute Max (NOT overridable) (Pediatric)** | 3 g/L peripheral; 8 g/L central |
| **Notes** | *Limited by Ca/Phos solubility curve. *Optimal Ca/Phos ratio 1.3-1.7:1 for bones. *Fluid restriction may limit Ca |

---

### Phosphate

| Setting | Value |
|---------|-------|
| **Initial Dose** | 0.5-0.8 mM/kg/day (or max allowed) |
| **Dose Advance** | Increase per Ca/Phos ratio and lab |
| **Goal** | 1-2.5 mM/kg/day |
| **Max Dose in Protocol (Neonatal)** | 2.5 mmol/kg |
| **Overridable by Pharmacist?** | Yes |
| **Absolute Max (NOT overridable) (Neonatal)** | 25.1 mM/L peripheral; 30.1 mM/L central |
| **Max Dose in Protocol (Pediatric)** | 2.5 mmol/kg |
| **Overridable by Pharmacist? (Pediatric)** | Yes |
| **Absolute Max (NOT overridable) (Pediatric)** | 25.1 mM/L peripheral; 30.1 mM/L central |
| **Notes** | *Limited by Ca/Phos solubility curve |

---

### Magnesium

| Setting | Value |
|---------|-------|
| **Initial Dose** | 0.1-0.2 mEq/kg/d (usually left out 1st day of life if no labs) |
| **Dose Advance** | 0.1-0.2 lab |
| **Goal** | 0.2-0.5 mEq/kg/day |
| **Max Dose in Protocol (Neonatal)** | 1 mEq/kg |
| **Overridable by Pharmacist?** | Yes |
| **Absolute Max (NOT overridable) (Neonatal)** | None |
| **Max Dose in Protocol (Pediatric)** | 1.75 mEq/kg (max 70 mEq) |
| **Overridable by Pharmacist? (Pediatric)** | Yes |
| **Absolute Max (NOT overridable) (Pediatric)** | None |
| **Notes** | *Renally cleared electrolyte. *Cardiac patients will have Mg goal levels. *Dose adjustment impacted by repletion doses, diuretic changes, and organ function, enteral repletions, drug-related hypo/hypermagnesemia |

---

### Heparin

| Setting | Value |
|---------|-------|
| **Initial Dose** | NICU: 0.5 units/mL central line (some providers prefer 1 unit/mL if lower rate and type of line). OK to add to peripheral TPN if it might run central once line access is established |
| **Dose Advance** | — |
| **Goal** | — |
| **Max Dose in Protocol (Neonatal)** | 2 units/mL |
| **Overridable by Pharmacist?** | Yes |
| **Absolute Max (NOT overridable) (Neonatal)** | None |
| **Max Dose in Protocol (Pediatric)** | 2 units/mL |
| **Overridable by Pharmacist? (Pediatric)** | Yes |
| **Absolute Max (NOT overridable) (Pediatric)** | None |
| **Notes** | **Do not exceed 5 units/kg/hr** |

---

### Copper

| Setting | Value |
|---------|-------|
| **Initial Dose** | 20 mcg/kg/d |
| **Dose Advance** | Per lab |
| **Goal** | Per lab |
| **Max Dose in Protocol (Neonatal)** | 40 mcg/kg (max 1000 mcg) |
| **Overridable by Pharmacist?** | Yes |
| **Absolute Max (NOT overridable) (Neonatal)** | None |
| **Max Dose in Protocol (Pediatric)** | 40 mcg/kg (max 1000 mcg) |
| **Overridable by Pharmacist? (Pediatric)** | Yes |
| **Absolute Max (NOT overridable) (Pediatric)** | None |
| **Notes** | *Consider dose reduction if elevated direct bilirubin >2 (if copper levels available, dose by level) |

---

### Selenium

| Setting | Value |
|---------|-------|
| **Initial Dose** | Preterm (<37wk GA): 3 mcg/kg/d at initiation; Low selenium levels: 2 mcg/kg/d |
| **Dose Advance** | Per lab |
| **Goal** | Per lab |
| **Max Dose in Protocol (Neonatal)** | 6 mcg/kg (max 150 mcg) |
| **Overridable by Pharmacist?** | Yes |
| **Absolute Max (NOT overridable) (Neonatal)** | None |
| **Max Dose in Protocol (Pediatric)** | 6 mcg/kg (max 150 mcg) |
| **Overridable by Pharmacist? (Pediatric)** | Yes |
| **Absolute Max (NOT overridable) (Pediatric)** | None |
| **Notes** | *Trace element labs (Cu, Zn, Se) initially checked monthly (or sooner if risk of deficiency/toxicity) |

---

### Carnitine

| Setting | Value |
|---------|-------|
| **Initial Dose** | 10-20 mg/kg/day if TG elevated or patient with liver or kidney disease |
| **Dose Advance** | — |
| **Goal** | — |
| **Max Dose in Protocol (Neonatal)** | 20 mg/kg (max 1000 mg) |
| **Overridable by Pharmacist?** | Yes |
| **Absolute Max (NOT overridable) (Neonatal)** | None |
| **Max Dose in Protocol (Pediatric)** | 20 mg/kg (max 1000 mg) |
| **Overridable by Pharmacist? (Pediatric)** | Yes |
| **Absolute Max (NOT overridable) (Pediatric)** | None |
| **Notes** | Helps with TG metabolism |

---

### Famotidine

| Setting | Value |
|---------|-------|
| **Initial Dose** | GERD: 0.5-1 mg/kg/day; Stress ulcer prophylaxis: 0.25-0.5 mg/kg/day; Reduce dose by 50% if renal dysfunction |
| **Dose Advance** | — |
| **Goal** | — |
| **Max Dose in Protocol (Neonatal)** | 2 mg/kg (max 80 mg) |
| **Overridable by Pharmacist?** | Yes |
| **Absolute Max (NOT overridable) (Neonatal)** | None |
| **Max Dose in Protocol (Pediatric)** | 2 mg/kg (max 80 mg) |
| **Overridable by Pharmacist? (Pediatric)** | Yes |
| **Absolute Max (NOT overridable) (Pediatric)** | None |
| **Notes** | Only added if indication exists |

---

### Acetate and Chloride

| Setting | Value |
|---------|-------|
| **Initial Dose** | Adjust as needed to maintain acid-base balance |
| **Dose Advance** | — |
| **Goal** | N/A |
| **Max Dose in Protocol** | N/A |
| **Notes** | *Acetate usually min if serum CO2 elevated (converted to bicarbonate). *Trophamine 1 g/kg/= Acetate ~1 mEq/kg (buffer). *Additional acetate/chloride/phos needs K or Na to formulate |

---

## Key Clinical Reminders

1. **EFAD Prevention**: Minimum Intralipid 0.5-1.5 g/kg/day; Minimum SMOFlipid 1.5-2.5 g/kg/day
2. **Lipid Maximum**: Should not exceed >60% total daily calories (except ketogenic diet)
3. **Hold Lipids**: If on dexlipidine or propofol; if severe fluid restriction (CVICU)
4. **Potassium Max Infusion Rate**: 0.5 mEq/kg/hr
5. **Heparin Max**: Do not exceed 5 units/kg/hr
6. **Ca/Phos Ratio**: Optimal 1.3-1.7:1 for bone health
7. **Trace Elements**: Cu, Zn, Se labs initially checked monthly (or sooner if risk of deficiency/toxicity)
8. **Copper**: Consider dose reduction if direct bilirubin >2
9. **Day 1 of Life**: Usually minimize sodium; usually no potassium; may omit magnesium if no labs
10. **GIR Formula**: GIR (mg/kg/min) = % Dextrose × rate of infusion (mL/hr) ÷ 10 ÷ Weight (kg) × 6 ÷ 11
